lansoprazole orally disintegrating tablets approved by us fda
Post on 09-Dec-2016
214 views
TRANSCRIPT
Inpharma 1446 - 17 Jul 2004
■ The US FDA has approved the use of delayed-release orally disintegrating tablets of lansoprazole,[Prevacid; TAP Pharmaceutical Products], administeredvia an oral syringe or nasogastric tube, for the short-term treatment of gastro-oesphageal reflux diseasesymptoms.TAP Pharmaceutical Products Inc. FDA Approves New Dosing Options forPREVACID(R) (LANSOPRAZOLE) SoluTab(TM) Orally DisintegratingTablets. Media Release : 6 Jul 2004. Available from: URL: http://www.tap.com 809036780
1
Inpharma 17 Jul 2004 No. 14461173-8324/10/1446-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved